Medicine & Life Sciences

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Follicular Lymphoma 61%
3. Lymphoma 53%
4. Survival 45%
5. Progression-Free Survival 44%
6. Ovarian Neoplasms 37%
7. Rituximab 37%
8. Non-Hodgkin's Lymphoma 31%
9. Neoplasms 19%
10. B-Cell Lymphoma 18%
11. Molecular Epidemiology 16%
12. Confidence Intervals 14%
13. B-Lymphocytes 13%
14. Therapeutics 13%
15. Mantle-Cell Lymphoma 13%
16. Single Nucleotide Polymorphism 12%
17. Peripheral T-Cell Lymphoma 12%
18. Recurrence 11%
19. Vincristine 11%
20. B-Cell Chronic Lymphocytic Leukemia 11%
21. Serum 11%
22. T-Lymphocytes 10%
23. Doxorubicin 10%
24. Cyclophosphamide 10%
25. epratuzumab 10%
26. Genes 9%
27. Ovarian Epithelial Carcinoma 9%
28. Hodgkin Disease 9%
29. Prednisone 9%
30. Drug Therapy 8%
31. T-Cell Lymphoma 8%
32. Cytokines 8%
33. Cohort Studies 7%
34. Light 7%
35. Anthracyclines 7%
36. Heterografts 7%
37. Clinical Trials 7%
38. Biomarkers 7%
39. Bicuspid Aortic Valve 7%
40. Bendamustine Hydrochloride 7%
41. Quality of Life 7%
42. Germinal Center 6%
43. Carcinoma 6%
44. Glioma 6%
45. Survivors 6%
46. Population 6%
47. Regulatory T-Lymphocytes 5%
48. Genetic Variation 5%
49. Platinum 5%
50. Prospective Studies 5%